The store will not work correctly when cookies are disabled.
sodium 2-[(Z)-[tert-butyl(oxido)iminio]methyl]benzenesulfonate
ID: ALA4475224
Cas Number: 73475-11-3
PubChem CID: 6508907
Max Phase: Preclinical
Molecular Formula: C11H14NNaO4S
Molecular Weight: 257.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)/[N+]([O-])=C/c1ccccc1S(=O)(=O)[O-].[Na+]
Standard InChI: InChI=1S/C11H15NO4S.Na/c1-11(2,3)12(13)8-9-6-4-5-7-10(9)17(14,15)16;/h4-8H,1-3H3,(H,14,15,16);/q;+1/p-1/b12-8-;
Standard InChI Key: LAIQBHGUFDAJKL-JCTPKUEWSA-M
Molfile:
RDKit 2D
18 17 0 0 0 0 0 0 0 0999 V2000
26.5768 -17.2071 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
25.0713 -13.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7886 -13.0989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4977 -13.5126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4977 -14.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7911 -14.7474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0713 -14.3391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7911 -15.5727 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
24.9636 -15.5727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.3752 -16.2851 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.2109 -14.7485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9282 -14.3338 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6414 -14.7485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3544 -14.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6414 -15.5739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3544 -15.1591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9282 -13.5126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.3745 -16.1560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3 2 2 0
4 3 1 0
5 4 2 0
6 5 1 0
7 6 2 0
2 7 1 0
6 8 1 0
8 9 2 0
8 10 2 0
5 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
13 15 1 0
13 16 1 0
12 17 1 0
8 18 1 0
M CHG 4 1 1 12 1 17 -1 18 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 257.31 | Molecular Weight (Monoisotopic): 257.0722 | AlogP: 1.66 | #Rotatable Bonds: 2 |
Polar Surface Area: 80.44 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: -1.94 | CX Basic pKa: ┄ | CX LogP: -1.26 | CX LogD: -1.61 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.29 | Np Likeness Score: -0.55 |
References
1. (2013) Compositions and methods of inhibiting retinal degeneration, |